Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study
Hester J. Scheffer(Amsterdam UMC Location Vrije Universiteit Amsterdam), Martijn R. Meijerink(Amsterdam University Medical Centers), Marleen C. A. M. Melenhorst(Maine Farmland Trust), Tanja D. de Gruijl(Dutch Cancer Society), Jantien A. Vogel(Amsterdam UMC Location University of Amsterdam), Cornelis van Kuijk(Amsterdam UMC Location VUmc), Geert Kazemier(European Organisation for Research and Treatment of Cancer), Babs M. Zonderhuis(Unknown), Foke van Delft(Maine Farmland Trust), M.A.E. de van der Schueren(HAN University of Applied Sciences), Laurien G. P. H. Vroomen(Amsterdam University Medical Centers), Freek Daams(Maine Farmland Trust), Anita G.M. Stam(Vrije Universiteit Amsterdam), Marcus C. de Jong(Amsterdam University Medical Centers), Jill Witvliet(Maine Farmland Trust), Petrousjka M. P. van den Tol(Amsterdam University Medical Centers), Marc G. Besselink(Amsterdam Neuroscience)
Cited by 138
Related Papers
ESPEN guidelines on nutrition in cancer patients
|Clinical Nutrition|2016|3k
ESPEN practical guideline: Clinical Nutrition in cancer
|Clinical Nutrition|2021|1.4k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k